Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Roly Gosling, PhD, MS

    TitleAssociate Professor
    SchoolUCSF School of Medicine
    DepartmentEpidemiology & Biostatistics
    Address50 Beale Street
    San Francisco CA 94143
    Phone415-597-8114

       Overview 
       Overview
      The malaria elimination initiative is focussed on supporting countries to succeed in elimination of both falciparum and vivax malaria. We have a broad range of activities from desk based research producing advocacy and summary materials to highlight the substantial progress of malaria control and elimination world wide, to field based research exploring active surveillance strategies, efficacy of drug based transmission interventions, costing studies of elimination programs and more qualitative research such as case studies. The program also supports countries by supporting regional networks of countries to eliminate malaria (the Asia Pacific Malaria Elimination Network, APMEN and the Eliminating 8, E8 in southern Africa).

      We do have opportunities to send students to support field research studies.


       ORNG Applications 
       Websites

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Koita K, Novotny J, Kunene S, Zulu Z, Ntshalintshali N, Gandhi M, Gosling R. Targeting imported malaria through social networks: a potential strategy for malaria elimination in Swaziland. Malar J. 2013; 12(1):219.
        View in: PubMed
      2. Gosling RD, Whittaker M, Gueye CS, Fullman N, Baquilod M, Kusriastuti R, Feachem RG. Malaria elimination gaining ground in the Asia Pacific. Malar J. 2012; 11:346.
        View in: PubMed
      3. Modrek S, Liu J, Gosling R, Feachem RG. The economic benefits of malaria elimination: do they include increases in tourism? Malar J. 2012; 11:244.
        View in: PubMed
      4. Stone W, Bousema T, Jones S, Gesase S, Hashim R, Gosling R, Carneiro I, Chandramohan D, Theander T, Ronca R, Modiano D, Arcà B, Drakeley C. IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One. 2012; 7(6):e40170.
        View in: PubMed
      5. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, Ghani A, Drakeley C, Gosling R. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012 Jan; 9(1):e1001165.
        View in: PubMed
      6. Yangzom T, Gueye CS, Namgay R, Galappaththy GN, Thimasarn K, Gosling R, Murugasampillay S, Dev V. Malaria control in Bhutan: case study of a country embarking on elimination. Malar J. 2012; 11:9.
        View in: PubMed
      7. Kunene S, Phillips AA, Gosling RD, Kandula D, Novotny JM. A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa. Malar J. 2011; 10:313.
        View in: PubMed
      8. Gosling RD, Okell L, Mosha J, Chandramohan D. The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect. 2011 Nov; 17(11):1617-23.
        View in: PubMed
      9. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, Semvua S, Masokoto A, Mosha F, Teelen K, Hermsen R, Okell L, Gosling R, Sauerwein R, Bousema T. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J. 2011; 10:247.
        View in: PubMed
      10. Bousema T, Kreuels B, Gosling R. Adjusting for heterogeneity of malaria transmission in longitudinal studies. J Infect Dis. 2011 Jul 1; 204(1):1-3.
        View in: PubMed
      11. Cairns M, Ghani A, Okell L, Gosling R, Carneiro I, Anto F, Asoala V, Owusu-Agyei S, Greenwood B, Chandramohan D, Milligan P. Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children. PLoS One. 2011; 6(4):e18947.
        View in: PubMed
      12. Griffin JT, Cairns M, Ghani AC, Roper C, Schellenberg D, Carneiro I, Newman RD, Grobusch MP, Greenwood B, Chandramohan D, Gosling RD. Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One. 2010; 5(9):e12618.
        View in: PubMed
      13. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, Biao P, Masika P, Matovu F, Otieno P, Gosling RD, Hamel M, Odhiambo FO, Grobusch MP, Kremsner PG, Chandramohan D, Aponte JJ, Egan A, Schellenberg D, Macete E, Slutsker L, Newman RD, Alonso P, Menéndez C, Tanner M. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One. 2010; 5(6):e10313.
        View in: PubMed
      14. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, Otieno S, Carneiro I, Cox J, Msuya E, Kleinschmidt I, Maxwell C, Greenwood B, Riley E, Sauerwein R, Chandramohan D, Gosling R. Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis. 2010 Jun 1; 201(11):1764-74.
        View in: PubMed
      15. Gosling RD, Cairns ME, Chico RM, Chandramohan D. Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther. 2010 May; 8(5):589-606.
        View in: PubMed
      16. Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS One. 2010; 5(3):e9467.
        View in: PubMed
      17. Mosha JF, Conteh L, Tediosi F, Gesase S, Bruce J, Chandramohan D, Gosling R. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One. 2010; 5(1):e8707.
        View in: PubMed
      18. Yip K, Gosling RD, Jones V, Hosein IK. An unusual case of meningococcal meningitis complicated with subdural empyema in a 3 month old infant: a case report. Cases J. 2009; 2:6335.
        View in: PubMed
      19. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Oct 31; 374(9700):1521-32.
        View in: PubMed
      20. Cairns M, Gosling R, Gesase S, Mosha J, Greenwood B, Chandramohan D. Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Trans R Soc Trop Med Hyg. 2009 Dec; 103(12):1199-201.
        View in: PubMed
      21. Gysels M, Pell C, Mathanga DP, Adongo P, Odhiambo F, Gosling R, Akweongo P, Mwangi R, Okello G, Mangesho P, Slutsker L, Kremsner PG, Grobusch MP, Hamel MJ, Newman RD, Pool R. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J. 2009; 8:191.
        View in: PubMed
      22. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009; 4(6):e6083.
        View in: PubMed
      23. Gosling RD, Chandramohan D. RTS,S/AS01E vaccine against malaria. N Engl J Med. 2009 Mar 19; 360(12):1253; author reply 1253-4.
        View in: PubMed
      24. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One. 2009; 4(2):e4569.
        View in: PubMed
      25. Cairns M, Gosling R, Chandramohan D. Placental malaria increases malaria risk in the first 30 months of life: not causal. Clin Infect Dis. 2009 Feb 15; 48(4):497-8; author reply 498-9.
        View in: PubMed
      26. Ghani AC, Sutherland CJ, Riley EM, Drakeley CJ, Griffin JT, Gosling RD, Filipe JA. Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS One. 2009; 4(2):e4383.
        View in: PubMed
      27. Mwanziva C, Shekalaghe S, Ndaro A, Mengerink B, Megiroo S, Mosha F, Sauerwein R, Drakeley C, Gosling R, Bousema T. Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J. 2008; 7:232.
        View in: PubMed
      28. Gosling RD, Chandramohan D. Tackling malaria today: Beware resurgence of malaria where incidence has fallen. BMJ. 2008; 337:a1592.
        View in: PubMed
      29. Gosling RD, Drakeley CJ, Mwita A, Chandramohan D. Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malar J. 2008; 7:132.
        View in: PubMed
      30. Gosling RD. Asymptomatic malaria associated with protection: not causal. Clin Infect Dis. 2008 Jul 1; 47(1):147; author reply 147-8.
        View in: PubMed
      31. Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, Gosling R, Greenwood B, Chandramohan D. Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS One. 2008; 3(5):e2227.
        View in: PubMed
      32. Gosling RD, Ghani AC, Deen JL, von Seidlein L, Greenwood BM, Chandramohan D. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malar J. 2008; 7:54.
        View in: PubMed
      33. Gosling RD, Drakeley CJ, Chandramohan D. Effective malaria control: better burden estimates needed. Lancet. 2008 Mar 1; 371(9614):724.
        View in: PubMed
      34. Whitty C, Gosling R. Implications of attempts to eliminate malaria for front-line clinicians. Trop Doct. 2008 Jan; 38(1):1-2.
        View in: PubMed
      35. Grobusch MP, Egan A, Gosling RD, Newman RD. Intermittent preventive therapy for malaria: progress and future directions. Curr Opin Infect Dis. 2007 Dec; 20(6):613-20.
        View in: PubMed
      36. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One. 2007; 2(10):e1023.
        View in: PubMed
      37. Masika PM, Semarundu WJ, Urassa R, Mosha J, Chandramohan D, Gosling RD. Over-diagnosis of malaria is not a lost cause. Malar J. 2006; 5:120.
        View in: PubMed
      38. Gosling RD, Schellenberg DM, Chandramohan D. Single-dose sulfadoxine-pyrimethamine in intermittent preventive treatment of malaria. J Infect Dis. 2006 Jun 1; 193(11):1609-10; author reply 1610-1.
        View in: PubMed
      39. Gillespie SH, Gosling RD, Uiso L, Sam NE, Kanduma EG, McHugh TD. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J Antimicrob Chemother. 2005 Dec; 56(6):1169-71.
        View in: PubMed
      40. Drakeley C, Gosling R, Reyburn H. Malaria diagnosis and treatment: one size does not fit all. PLoS Med. 2005 Jun; 2(6):e156; author reply e165.
        View in: PubMed
      41. Gosling RD, Uiso LO, Sam NE, Bongard E, Kanduma EG, Nyindo M, Morris RW, Gillespie SH. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 2003 Dec 1; 168(11):1342-5.
        View in: PubMed
      42. Gosling RD, Heifets L, Gillespie SH. A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs. J Antimicrob Chemother. 2003 Sep; 52(3):473-6.
        View in: PubMed
      43. Gillespie SH, Gosling RD, Charalambous BM. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. Am J Respir Crit Care Med. 2002 Jul 1; 166(1):31-5.
        View in: PubMed
      Roly's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP